ClinConnect ClinConnect Logo
Search / Trial NCT02832193

Retrospective Evaluation of POCD Data of Studies From KAI, Charité - Universitätsmedizin Berlin

Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jul 11, 2016

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a condition called postoperative cognitive dysfunction (POCD), which is a decline in cognitive abilities like memory and thinking after surgery. The goal is to gather information from previous studies to better understand how common this issue is and how it can be prevented. Researchers are looking for participants who are planning to have elective surgery lasting at least one hour and are between the ages of 18 to 100. Both men and women can join, as long as they can give consent and understand the study instructions.

If you decide to participate, you'll be asked to provide written consent and share some of your health information. The study will not include those with certain medical conditions that could affect the results, such as severe hearing or visual impairments, or a history of neurological issues like strokes. It's also important to know that participants will be contacted after surgery for follow-up assessments. This study is currently recruiting, so if you meet the eligibility criteria and are interested in contributing to this important research, you might want to consider taking part.

Gender

ALL

Eligibility criteria

  • Study Group
  • Inclusion Criteria:
  • Age 18 -100 years
  • Male or female patients undergoing elective surgery expected to last at least 60 min, screened at the Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany
  • Written informed consent to participate after having been properly instructed
  • Exclusion Criteria:
  • Lacking willingness to take part in the study, or to have relevant study data collected, saved and analyzed for the purpose of the study
  • Accommodation in an institution due to an official or judicial order
  • Insufficient knowledge of German language
  • Members of the hospital staff
  • Homelessness or other conditions that disable reachability for postoperative assessment by post or telephone
  • Illiteracy
  • Patients who had a history of neurologic deficits (e.g. stroke, history of seizures, etc.)
  • Hearing impairment that severely affects the neuropsychological testing.
  • Visual impairment that severely affects the neuropsychological testing.
  • Participation in other prospective clinical interventional trials
  • Control Group
  • Inclusion Criteria:
  • Age 18 - 100 years
  • Male or female patients (ASA Status I, II+III)
  • No planned surgery during the next 3 months
  • No surgery during the past 6 months before study inclusion
  • Written informed consent to participate after having been properly instructed
  • Exclusion Criteria:
  • Insufficient knowledge of German language Lacking willingness to take part in the study, or to have relevant study data collected, saved and analyzed for the purpose of the study
  • Neuropsychiatric conditions that severely affect the neuropsychological testing
  • Hearing impairment that severely affects the neuropsychological testing
  • Visual impairment that severely affects the neuropsychological testing

About Charite University, Berlin, Germany

Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.

Locations

Berlin, , Germany

Berlin, , Germany

Patients applied

0 patients applied

Trial Officials

Claudia Spies, MD, Prof.

Study Director

Charite University, Berlin, Germany

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials